BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31317916)

  • 1. [Autoimmune mechanisms and new opportunities for treatment narcolepsy].
    Medvedeva AV; Golovatyuk AO; Poluektov MG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(4. Vyp. 2):56-62. PubMed ID: 31317916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Narcolepsy: etiology, clinical features, diagnosis and treatment].
    Zawilska JB; Woldan-Tambor A; Płocka A; Kużajska K; Wojcieszak J
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():771-86. PubMed ID: 23175331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocretin/orexin and narcolepsy: new basic and clinical insights.
    Nishino S; Okuro M; Kotorii N; Anegawa E; Ishimaru Y; Matsumura M; Kanbayashi T
    Acta Physiol (Oxf); 2010 Mar; 198(3):209-22. PubMed ID: 19555382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
    Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
    Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights.
    Ritchie C; Okuro M; Kanbayashi T; Nishino S
    Curr Neurol Neurosci Rep; 2010 May; 10(3):180-9. PubMed ID: 20425033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcolepsy in the pediatric population.
    Viorritto EN; Kureshi SA; Owens JA
    Curr Neurol Neurosci Rep; 2012 Apr; 12(2):175-81. PubMed ID: 22213222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcolepsy.
    Barateau L; Pizza F; Plazzi G; Dauvilliers Y
    J Sleep Res; 2022 Aug; 31(4):e13631. PubMed ID: 35624073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Narcolepsy with cataplexy: an autoimmune disease?].
    Jacob L; Dauvilliers Y
    Med Sci (Paris); 2014 Dec; 30(12):1136-43. PubMed ID: 25537044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for narcolepsy.
    Abad VC; Guilleminault C
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narcolepsy: a review of evidence for autoimmune diathesis.
    Black JL
    Int Rev Psychiatry; 2005 Dec; 17(6):461-9. PubMed ID: 16401544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleepiness that cannot be overcome: narcolepsy and cataplexy.
    Han F
    Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
    Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
    Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
    Dauvilliers Y; Lopez R
    Rev Prat; 2016 Jun; 66(6):671-6. PubMed ID: 27538328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.